One caveat the literature is honest about: as of May 2026, no randomized controlled trial has yet tested resistance training as a counter-measure specifically to GLP-1-induced lean-mass loss
Hims & Hers expects its weight loss business to bring in $725 million in revenue in 2025, Okupe told investors Monday
A metabolism that slows instead of strengthens
Front Endocrinol (Lausanne) (2021) 12:738848
It is tempting to speculate that this apparent loss of benefit in patients with more advanced HF may be the result of increases in HR caused by activation of sinoatrial node (SAN) GLP-1Rs (64, 65), which could be mitigated with an agent such as GLP-1(2836) that retains cardiac and vascular protection of GLP-1, without activating the GLP-1R
Now, the real-world use is broader, messierand more revealing